Jeffrey M. Fryer
Geen lopende functies
Vermogen: 1 M $ op 29-02-2024
Profiel
Founder of Rallybio Corp.
and Rallybio LLC, Jeffrey M.
Fryer is former Chief Financial Officer & Treasurer for Rallybio Corp.
and former Chief Tax Officer & Vice President at Alexion Pharmaceuticals, Inc.
Mr. Fryer received a graduate degree from the University of Hartford and an undergraduate degree from Bryant University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
RALLYBIO CORPORATION
1.67% | 31-03-2023 | 632 370 ( 1.67% ) | 1 M $ | 29-02-2024 |
Eerdere bekende functies van Jeffrey M. Fryer
Bedrijven | Functie | Einde |
---|---|---|
RALLYBIO CORPORATION | Founder | 01-02-2023 |
ALEXION PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01-04-2017 |
Rallybio LLC
Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT. | Founder | - |
Opleiding van Jeffrey M. Fryer
University of Hartford | Graduate Degree |
Bryant University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
RALLYBIO CORPORATION | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Rallybio LLC
Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT. | Commercial Services |